Guidelines For Manufacturing, Distribution  And Registration Of Medicines Revised.

Stakeholders in the Manufacturing, Distribution  and Registration of medicines are undergoing a workshop in Accra in the revised guidelines for registration of orthodox medicines. 


The Acting Deputy Chief Executive in charge of Drug Registration and Inspectorate Division of the Food and Drugs Authority, FDA, Seth Seaneke, says the Authority is to ensure that medicinal application and registration by players in the industry conform with  FDA as well as international standards.


 Mr. Seaneke noted that the revised guidelines will make it easier for manufacturers and regulators to trade their products on the local as well as international markets. 


Mr. Seaneke warned that the authority will not succumb to manufacturers and pharmaceutical companies who flout the new and revised guidelines.

Source : GBC